Biomea Fusion Inc (BMEA)
12.22
-0.56
(-4.38%)
USD |
NASDAQ |
May 17, 16:00
12.22
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Total Liabilities (Quarterly): 33.18M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 33.18M |
| December 31, 2023 | 30.69M |
| September 30, 2023 | 25.48M |
| June 30, 2023 | 24.37M |
| March 31, 2023 | 29.51M |
| December 31, 2022 | 20.77M |
| September 30, 2022 | 14.42M |
| Date | Value |
|---|---|
| June 30, 2022 | 11.35M |
| March 31, 2022 | 10.10M |
| December 31, 2021 | 6.922M |
| September 30, 2021 | 8.072M |
| June 30, 2021 | 7.517M |
| March 31, 2021 | 59.65M |
| December 31, 2020 | 57.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.922M
Minimum
Dec 2021
59.65M
Maximum
Mar 2021
24.24M
Average
22.57M
Median
Total Liabilities (Quarterly) Benchmarks
| Poseida Therapeutics Inc | 177.99M |
| Cartesian Therapeutics Inc | 442.01M |
| BioXcel Therapeutics Inc | 154.69M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 168.49M |
| Shareholders Equity (Quarterly) | 135.31M |